SIERRA MADRE, Calif., Dec. 8, 2011 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., (OTCBB:NORHD) (“Innovus) Pharma”) today announced that FasTrack Pharmaceuticals, Inc. (“FasTrack”), completed its previously announced merger agreement with North Horizon Inc., subsequent to which FasTrack was acquired by, and has become a wholly-owned subsidiary of North Horizon. Effective December 7, 2011, the combined entity began operating under the name of Innovus Pharma. Its common stock will continue to be quoted on the OTC Bulletin Board under the ticker: NORHD until January 18, 2012, after which time it will trade under the ticker: INNV.
